319 related articles for article (PubMed ID: 19403663)
1. Adenovirus vectors expressing hantavirus proteins protect hamsters against lethal challenge with andes virus.
Safronetz D; Hegde NR; Ebihara H; Denton M; Kobinger GP; St Jeor S; Feldmann H; Johnson DC
J Virol; 2009 Jul; 83(14):7285-95. PubMed ID: 19403663
[TBL] [Abstract][Full Text] [Related]
2. Vesicular stomatitis virus-based vaccine protects hamsters against lethal challenge with Andes virus.
Brown KS; Safronetz D; Marzi A; Ebihara H; Feldmann H
J Virol; 2011 Dec; 85(23):12781-91. PubMed ID: 21917979
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the protective efficacy of naked DNA, DNA-based Sindbis replicon, and packaged Sindbis replicon vectors expressing Hantavirus structural genes in hamsters.
Kamrud KI; Hooper JW; Elgh F; Schmaljohn CS
Virology; 1999 Oct; 263(1):209-19. PubMed ID: 10544095
[TBL] [Abstract][Full Text] [Related]
4. Immune serum produced by DNA vaccination protects hamsters against lethal respiratory challenge with Andes virus.
Hooper JW; Ferro AM; Wahl-Jensen V
J Virol; 2008 Feb; 82(3):1332-8. PubMed ID: 18032485
[TBL] [Abstract][Full Text] [Related]
5. Cross-protection against challenge with Puumala virus after immunization with nucleocapsid proteins from different hantaviruses.
de Carvalho Nicacio C; Gonzalez Della Valle M; Padula P; Björling E; Plyusnin A; Lundkvist A
J Virol; 2002 Jul; 76(13):6669-77. PubMed ID: 12050380
[TBL] [Abstract][Full Text] [Related]
6. Long-term single-dose efficacy of a vesicular stomatitis virus-based Andes virus vaccine in Syrian hamsters.
Prescott J; DeBuysscher BL; Brown KS; Feldmann H
Viruses; 2014 Jan; 6(2):516-23. PubMed ID: 24492621
[TBL] [Abstract][Full Text] [Related]
7. Active and passive vaccination against hantavirus pulmonary syndrome with Andes virus M genome segment-based DNA vaccine.
Custer DM; Thompson E; Schmaljohn CS; Ksiazek TG; Hooper JW
J Virol; 2003 Sep; 77(18):9894-905. PubMed ID: 12941899
[TBL] [Abstract][Full Text] [Related]
8. Induction of protective immunity in a Syrian hamster model against a cytopathogenic strain of Andes virus.
Martinez VP; Padula PJ
J Med Virol; 2012 Jan; 84(1):87-95. PubMed ID: 22095538
[TBL] [Abstract][Full Text] [Related]
9. Neutralizing Monoclonal Antibodies against the Gn and the Gc of the Andes Virus Glycoprotein Spike Complex Protect from Virus Challenge in a Preclinical Hamster Model.
Duehr J; McMahon M; Williamson B; Amanat F; Durbin A; Hawman DW; Noack D; Uhl S; Tan GS; Feldmann H; Krammer F
mBio; 2020 Mar; 11(2):. PubMed ID: 32209676
[TBL] [Abstract][Full Text] [Related]
10. Polyclonal alpaca antibodies protect against hantavirus pulmonary syndrome in a lethal Syrian hamster model.
Sroga P; Sloan A; Warner BM; Tierney K; Lew J; Liu G; Chan M; Deschambault Y; Stein DR; Soule G; Banadyga L; Falzarano D; Safronetz D
Sci Rep; 2021 Aug; 11(1):17440. PubMed ID: 34465819
[TBL] [Abstract][Full Text] [Related]
11. A lethal disease model for New World hantaviruses using immunosuppressed Syrian hamsters.
Vergote V; Laenen L; Vanmechelen B; Van Ranst M; Verbeken E; Hooper JW; Maes P
PLoS Negl Trop Dis; 2017 Oct; 11(10):e0006042. PubMed ID: 29077702
[TBL] [Abstract][Full Text] [Related]
12. Depletion of Alveolar Macrophages Does Not Prevent Hantavirus Disease Pathogenesis in Golden Syrian Hamsters.
Hammerbeck CD; Brocato RL; Bell TM; Schellhase CW; Mraz SR; Queen LA; Hooper JW
J Virol; 2016 Jul; 90(14):6200-6215. PubMed ID: 27099308
[TBL] [Abstract][Full Text] [Related]
13. The adaptive immune response does not influence hantavirus disease or persistence in the Syrian hamster.
Prescott J; Safronetz D; Haddock E; Robertson S; Scott D; Feldmann H
Immunology; 2013 Oct; 140(2):168-78. PubMed ID: 23600567
[TBL] [Abstract][Full Text] [Related]
14. DNA vaccination with hantavirus M segment elicits neutralizing antibodies and protects against seoul virus infection.
Hooper JW; Kamrud KI; Elgh F; Custer D; Schmaljohn CS
Virology; 1999 Mar; 255(2):269-78. PubMed ID: 10069952
[TBL] [Abstract][Full Text] [Related]
15. Serological diagnosis with recombinant N antigen for hantavirus infection.
Yoshimatsu K; Arikawa J
Virus Res; 2014 Jul; 187():77-83. PubMed ID: 24487183
[TBL] [Abstract][Full Text] [Related]
16. Construction and nonclinical testing of a Puumala virus synthetic M gene-based DNA vaccine.
Brocato RL; Josleyn MJ; Wahl-Jensen V; Schmaljohn CS; Hooper JW
Clin Vaccine Immunol; 2013 Feb; 20(2):218-26. PubMed ID: 23239797
[TBL] [Abstract][Full Text] [Related]
17. Vesicular Stomatitis Virus-Based Vaccines Provide Cross-Protection against Andes and Sin Nombre Viruses.
Warner BM; Stein DR; Jangra RK; Slough MM; Sroga P; Sloan A; Frost KL; Booth S; Chandran K; Safronetz D
Viruses; 2019 Jul; 11(7):. PubMed ID: 31337019
[TBL] [Abstract][Full Text] [Related]
18. Differential lymphocyte and antibody responses in deer mice infected with Sin Nombre hantavirus or Andes hantavirus.
Schountz T; Quackenbush S; Rovnak J; Haddock E; Black WC; Feldmann H; Prescott J
J Virol; 2014 Aug; 88(15):8319-31. PubMed ID: 24829335
[TBL] [Abstract][Full Text] [Related]
19. Hantaan/Andes virus DNA vaccine elicits a broadly cross-reactive neutralizing antibody response in nonhuman primates.
Hooper JW; Custer DM; Smith J; Wahl-Jensen V
Virology; 2006 Mar; 347(1):208-16. PubMed ID: 16378630
[TBL] [Abstract][Full Text] [Related]
20. Hantavirus-like particles generated in CHO cells induce specific immune responses in C57BL/6 mice.
Li C; Liu F; Liang M; Zhang Q; Wang X; Wang T; Li J; Li D
Vaccine; 2010 Jun; 28(26):4294-300. PubMed ID: 20433802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
